Celastrol Inhibits Dopaminergic Neuronal Death of Parkinson's Disease through Activating Mitophagy
Parkinson’s disease (PD) is a neurodegenerative disease, which is associated with mitochondrial dysfunction and abnormal protein accumulation. No treatment can stop or slow PD. Autophagy inhibits neuronal death by removing damaged mitochondria and abnormal protein aggregations. Celastrol i...
Saved in:
Main Authors: | Ming-Wei Lin (Author), Chi Chien Lin (Author), Yi-Hung Chen (Author), Han-Bin Yang (Author), Shih-Ya Hung (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vulnerability of mesostriatal dopaminergic neurons in Parkinson's disease
by: Tomás González-Hernández, et al.
Published: (2010) -
Safranal-promoted differentiation and survival of dopaminergic neurons in an animal model of Parkinson's disease
by: Yi Zhao, et al.
Published: (2018) -
ALOX5 inhibition protects against dopaminergic neurons undergoing ferroptosis
by: Kun Li, et al.
Published: (2023) -
Celastrol inhibits store operated calcium entry and suppresses psoriasis
by: Xiaoman Yuan, et al.
Published: (2023) -
Suppressed microRNA-96 inhibits iNOS expression and dopaminergic neuron apoptosis through inactivating the MAPK signaling pathway by targeting CACNG5 in mice with Parkinson's disease
by: Yue Dong, et al.
Published: (2018)